12Month16On [date], SDIC Biomanufacturing Innovation Research Institute, a subsidiary of State Development & Investment Corp., and Taixing Dongsheng Biotechnology Co., Ltd.Sign the Equity Transfer Agreement, and launch the industrialization project for novel proteins,Ultimately, the SDIC Bio-Manufacturing Innovation Research Institute will hold a controlling stake in Dongsheng Biology.

According to reports, the State-owned Assets Supervision and Administration Commission of the State Council2023In [year], the implementation of the Industrial Renewal Action for Central State-Owned Enterprises and the Future Industries Launch Action was initiated, focusing on bio-manufacturing, new materials, and other sectors.15key industrial sectors.

Among them, SDIC Group is the lead entity for fostering and developing the biomanufacturing industry.2024Year12Month, SDIC Bio-Manufacturing Innovation Research Institute was established, with registered capital60billion yuan. As a state-owned capital investment company, SDIC Group takes “direct investment+“Dual-wheel drive” investment system of the fund, accelerating the cultivation of the biomanufacturing industry.

By managing national-level funds, SDIC Group leverages its existing industrial funds to invest in projects within the bio-manufacturing sector.118Quantity, Amount225100 million yuan, driving over 100 billion yuan in investment,The total market capitalization of portfolio companies exceeds one trillion.

Taking the biomedical and pharmaceutical sector as an example, SDIC has cumulatively invested98Number of Projects, Total Amount184100 million yuan, driving social capital investment of over1086hundred million yuan, with invested companies such as Innovent Biologics and Kelun-Biotech having grown into industry leaders.

Taixing Dongsheng Biotechnology Co., Ltd., which is now controlled by SDIC Holdings, was established in2007In the year, public information shows that Dongsheng Biology is the world's glutamine transaminase (TGenzyme) leading enterprise, with its products exported to Europe, the United States, Southeast Asia, and other regions43countries and regions,Domestic market share reaches60%，It is a national "Little Giant" enterprise specializing in specialized, refined, distinctive, and innovative products.

After SDIC Innovation Institute gains controlling interest in Dongsheng Biotech, it will establish Dongsheng Biotech as its core industrial platform. Leveraging Dongsheng Biotech’s existing explorations, practical experience, and industrial foundation in new-quality proteins—such as food enzyme preparations and mycelial protein—it will form a “scientific research-“Industry” two-way linkage, building a model for the integrated development of production and research in bio-manufacturing by central state-owned enterprises, accelerating the industrialization process of novel quality proteins, and creating a demonstration benchmark for high-quality development of the bio-manufacturing industry.

It is understood that the novel protein industry, as a typical representative of new quality productive forces in biomanufacturing, leverages synthetic biology technologies to reform and upgrade traditional methods of protein acquisition—such as crop farming and livestock breeding—through industrial microbial fermentation.

In fact, as early as2025Year5In [Month], SDIC Innovation Institute joined forces with Academician Chen Jian’s team from Jiangnan University to establish the Wuxi New Quality Protein Center, a new R&D institution in Wuxi High-Tech Zone, aiming to accelerate the supply of new quality protein technologies through collaborative innovation.

2025Year9Month, Wuxi New Quality Protein Center,Dongsheng Biology Signs Strategic Cooperation Agreement with Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, to Accelerate the Industrialization of Mycelial Protein

Wang Hao, Executive Deputy General Manager of Dongsheng Biotech, stated that Dongsheng Biotech has2020Around 2015, we began monitoring fungal protein projects and made preliminary attempts.However, the fungal protein project is not something that Dongsheng, a relatively small-scale private enterprise, can successfully implement on its own.SDIC Group has a long-term strategic layout and has made substantial investments; Dongsheng Biotechnology is willing to join its ranks.

Ma Yanhe, a strategic scientist specially invited by SDIC Group, pointed out that, overall, the global biomanufacturing industry is still in its early stages, characterized by “two large and two small” features:

• Supported by a large-scale platform,Technological innovation platforms host key resources such as R&D equipment and pilot-scale production bases, providing a solid technical foundation for the entire industry chain;

• Driven by small teams,Leveraging breakthroughs in frontier technologies such as synthetic biology, small teams composed of a few researchers can efficiently accomplish key innovations like strain engineering; these agile and efficient micro-innovation entities are widely distributed across China;

• Small product form,The market size for a single product is mostly concentrated in500010,000 yuan to5between 100 million yuan, exhibiting the niche characteristics of "specialized, refined, distinctive, and innovative" enterprises;

• Large Market Landscape,Countless specialized niche products and distinctive microbial strains, through synergistic combinations, have formed a vast market ecosystem spanning multiple sectors—including food, pharmaceuticals, materials, and energy—ultimately establishing an industry space valued in the trillions.

▲ Beauty Biomanufacturing

---

NMPA Issues Document, Benefiting Eight Major Cosmetic Ingredients

Eight National Filings Accepted Within One Year! Ergothioneine Market Heats Up

Jiangnan University Professor Kang Zhen: Cosmetics Is the Fastest-Growing Sector for Biomanufacturing Technology Applications

Jiangxi Explicitly Supports Plant-Derived Squalane, Niacinamide, Natural Tocopherol, and Other Ingredients

▲Biomanufacturing Enterprise Map

---

|Bloomage Biotech|Kelun Pharmaceutical|Sinopharm Modern|

|Angel Yeast|MicroWell Biotech|Jinbo Bio|

|Obio Technology|Brother Science & Technology|Chenguang Biotech丨

|Muyuan Shares|Microelement Synthesis|Tuoxin Pharmaceutical|

丨Huaheng Biotechnology|Zhenghai Biotechnology|Huadong Medicine|

|Laiyin Biology|Baoji Pharmaceutical|Chu Tian Technology|

|Yinhang Bio|Juyuan Bio|Hesheng Bio|

丨Microfar Biotech|Yixi Bio|Zhiyu Biosciences|

|Tianwu Technology|Manson Biology|Duality Biologics|